SEC Form 4 · accession 0000932440-17-000039
EAGLE PHARMACEUTICALS, INC. · EGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Jay Moorin
10% Owner
Alain Schreiber
10% Owner
ProQuest Investments IV, L.P.
10% Owner
ProQuest Associates IV LLC
10% Owner
ProQuest Financial LLC
10% Owner
Period of report
May 15, 2017
Accepted (ET)
May 15, 2017 · 8:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000827871
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock $0.001 par valueF3,F1 | May 15, 2017 | J | 3,584,087 | $0.00 | D | 0 | I | By ProQuest Investments IV, L.P. |
| Common Stock $0.001 par valueF3 | May 15, 2017 | J | 149,107 | $0.00 | A | 172,381 | I | By Jay Moorin directly and through IRA |
| Common Stock $0.001 par valueF3 | May 15, 2017 | J | 149,107 | $0.00 | A | 149,107 | I | By Alain Schreiber |
| Common Stock $0.001 par valueF2 | holding | — | — | — | 6,777 | I | By ProQuest Financial LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held by ProQuest Investments IV, L.P. ("Investments IV"), which ProQuest Financial LLC ("ProQuest Financial") manages. Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
- F2Jay Moorin and Alain Schreiber are managing members of ProQuest Financial and each of them disclaims beneficial ownership of such securities except to the extent of his pecuniary interest in such securities.
- F3Effective as of May 15, 2017, Investments IV distributed the shares to its partners for no additional consideration.